Related Experiment Videos
[Juvenile neuronal ceroid lipofuscinosis]
1Arhus Universitetshospital, Skejby Sygehus, børneafdelingen og klinisk genetisk afdeling.
Ugeskrift for Laeger
|July 10, 1998
Summary
Neuronal ceroid-lipofuscinosis (CLN) comprises neurodegenerative disorders marked by lipopigment accumulation. CLN3, or Spielmeyer-Vogt
Area of Science:
- Neuroscience and Genetics
- Cell Biology
- Medical Genetics
Context:
- Neuronal ceroid-lipofuscinosis (CLN) represents a group of rare, inherited neurodegenerative diseases.
- These disorders are characterized by the pathological accumulation of autofluorescent storage material (lipopigment) within lysosomes of neuronal and non-neuronal cells.
- Subclassification of CLN is based on clinical presentation, age of onset, and specific ultrastructural findings of the lipopigment.
Purpose:
- To provide an overview of Neuronal Ceroid Lipofuscinosis (CLN), including its classification and characteristics.
- To detail the clinical and genetic aspects of CLN3 (Spielmeyer-Vogt disease), the most prevalent subtype in Denmark.
- To briefly describe other subtypes of CLN for comprehensive understanding.
Summary:
- CLN is a spectrum of neurodegenerative diseases defined by intracellular lipopigment accumulation.
- CLN3 (Spielmeyer-Vogt disease), the most common form in Denmark, affects children aged 4-9 with visual and behavioral issues, progressing to seizures and psychomotor decline.
- CLN3 is caused by mutations in a gene on chromosome 16 (16p12.1), with most patients succumbing before age 30.
Impact:
- Enhances understanding of the genetic basis and clinical trajectory of CLN subtypes, particularly CLN3.
- Provides a foundation for future research into diagnostic markers and therapeutic strategies for these devastating neurodegenerative conditions.
- Contributes to the accurate classification and designation of CLN diseases using the international CLN nomenclature.